Wayne S McDonald

Title: Wayne S. McDonald: Innovator in Chemokine Receptor Activity

Introduction

Wayne S. McDonald is a notable inventor based in East Lyme, Connecticut. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of chemokine receptor activity. His work focuses on developing compounds that can effectively target specific receptors associated with various diseases.

Latest Patents

Wayne S. McDonald holds 1 patent for his invention titled "Modulators of chemokine receptor activity." This patent describes chemokine receptor antagonists, specifically bicyclic diamine compounds of Formula (I). These compounds act as antagonists of the chemokine CCR2 and CCR3 receptors. The patent outlines pharmaceutical compositions and their uses in treating or preventing diseases linked to monocyte, lymphocyte, or leucocyte accumulation.

Career Highlights

Wayne is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development of innovative therapeutic solutions aimed at improving patient outcomes. His expertise in chemokine receptor activity has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Wayne has collaborated with several professionals in his field, including Roberto Colon-Cruz and Mary Theresa Didiuk. These collaborations have enhanced the research and development processes, leading to advancements in therapeutic applications.

Conclusion

Wayne S. McDonald is a distinguished inventor whose work in chemokine receptor activity has the potential to impact the treatment of various diseases. His contributions to the pharmaceutical industry exemplify the importance of innovation in healthcare.